Africa
Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
There are 7 billion people in the world. Of those, 5 billion have access to life-saving medications, while 2 billion do not. That is a gap that pharmaceutical companies can help close through increased R&D programs, logistical initiatives and the lowering of prices, the Access to Medicine Foundation announced Tuesday.
As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.
Two antimalarial strategies have been published from Imperial College London in the past month: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.
This Latest move is a wide-ranging effort to boost competitiveness.
What are the risks and benefits of taking such a step? And what factors are important to consider before doing so?
Biotech has been on fire this year, with the iShare Nasdaq Biotechnology index more than doubling the gains of the S&P 500 year-to-date.
PRESS RELEASES